share_log

国金证券股份有限公司关于江苏吉贝尔药业股份有限公司2024年半年度持续督导跟踪报告

Guojin Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Jiangsu Gibel Pharmaceutical Co., Ltd.

SZSI ·  Aug 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more